Aptevo Therapeutics Inc. Discontinued Operation, Tax Effect of Discontinued Operation
Aptevo Therapeutics Inc. (APVO) reported Discontinued Operation, Tax Effect of Discontinued Operation of $1.58 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation · last filed 2020-11-10
- Aptevo Therapeutics Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Aptevo Therapeutics Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2020-03-31 was $1.58M, a 470.40% increase year-over-year.
- Aptevo Therapeutics Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2019-09-30 was $999.00K.
- Aptevo Therapeutics Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2019-06-30 was $2.49M.
- Aptevo Therapeutics Inc. discontinued operation, tax effect of discontinued operation for fiscal 2017 was $23.30M, a 435.36% increase from fiscal 2016.
- Aptevo Therapeutics Inc. discontinued operation, tax effect of discontinued operation for fiscal 2016 was $4.35M.
| Period end | Discontinued Operation, Tax Effect of Discontinued Operation 3 month | Discontinued Operation, Tax Effect of Discontinued Operation 6 month | Discontinued Operation, Tax Effect of Discontinued Operation 9 month | Discontinued Operation, Tax Effect of Discontinued Operation 12 month |
|---|---|---|---|---|
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $1.58M 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | $1.58M 10-Q · filed 2020-05-13 | |||
| 2019-09-30 | $999.00K 10-Q · filed 2020-11-10 | $3.49M derived: sum of 2 quarters · filed 2020-11-10 | $999.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $2.49M 10-Q · filed 2020-08-14 | $2.77M 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $277.00K 10-Q · filed 2020-05-13 | |||
| 2017-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $21.48M derived: sum of 2 quarters · filed 2019-03-18 | $22.48M derived: sum of 3 quarters · filed 2019-03-18 | $23.30M 10-K · filed 2019-03-18 |
| 2017-09-30 | $21.26M 10-Q · filed 2018-11-14 | $22.25M derived: sum of 2 quarters · filed 2018-11-14 | $23.08M 10-Q · filed 2018-11-14 | $24.18M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $996.00K 10-Q · filed 2018-08-09 | $1.82M 10-Q · filed 2018-08-09 | $2.92M derived: sum of 3 quarters · filed 2018-08-09 | $5.21M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $823.00K 10-Q · filed 2018-05-10 | $1.93M derived: sum of 2 quarters · filed 2018-05-10 | $4.22M derived: sum of 3 quarters · filed 2018-05-10 | |
| 2016-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $3.39M derived: sum of 2 quarters · filed 2018-03-13 | $4.35M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $2.29M 10-Q · filed 2017-11-13 | $3.25M 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |